SIRS-Lab produces molecular diagnostic test-systems to identify life-threatening infections. The main objective is to enable early and targeted antibiotic therapy of sepsis, a leading cause of death in hospitals. With expert knowledge in critical care medicine, microbiology, assay design, and gene expression, SIRS-Lab builds a unique diagnostic portfolio.
- 05.05.08
SIRS-Lab at Austria’s Top Diagnostic Events

After the successful ECCMID in Barcelona, the VYOO sepsis test Roadshow continues its successful journey throughout Europe and stops for two outstanding meetings in Graz, Austria:
May 13-17, Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Booth 6
May 22-24, International Symposium on Molecular Diagnostics (ISMD), Booth 5
These symposia assemble the top innovators in molecular diagnostics. Within the excellent scientific program, we especially recommend...
read more »
- 28.03.08
Excellent workshop program published

In the course of the International Shock Congress (Cologne June 28 – July 2), SIRS-Lab will host the cutting edge workshop “Microarray – Tool or Toy”. Register now for the congress and join the workshop with lectures from: Michael Bauer, Friedemann Horn, Matthias Kohl, Lyle L. Moldawer, Chris Thiemermann, and Yoram Vodovotz. Read more about the workshop program, registration (discount prior to April 15), and the congress here…
read more »





![[Keine Beschreibung eingegeben]](/files/produktbutton_vyoo_1.jpg)
![[LOOXSTER sample preparation]](/files/produktbutton_looxster_1.jpg)
